Robotic-assisted thoracoscopic segmentectomy: there is a long way to go

Li, Chengqiang; Li, Hecheng

doi:10.21037/jtd.2017.10.81

Cited by 2 publications

(2 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, few articles on robotic segmentectomy have been published [4,5,18]. Although these aforementioned reports have shown that the technique provides safe and feasible outcomes, concerns remain regarding its applicability outside of specialized centers [19]. In addition, to the best of our knowledge, the learning curve of robotic segmentectomy has yet to be reported.…”

Section: Commentmentioning

confidence: 99%

Robotic Anatomical Segmentectomy: An Analysis of the Learning Curve

Zhang

Liu

Han

et al. 2019

The Annals of Thoracic Surgery

Self Cite

View full text Add to dashboard Cite

Section: Commentmentioning

confidence: 99%

Robotic Anatomical Segmentectomy: An Analysis of the Learning Curve

Zhang

Liu

Han

et al. 2019

The Annals of Thoracic Surgery

Self Cite

View full text Add to dashboard Cite

“…The signi cance of cancer screening is to detect early cancer, provide more treatment options for patients and improve the survival rate [4][5][6][7][8] . Some early lesions can also be found, and timely treatment measures can be taken to avoid the development of mild lesions to the direction of cancer; Through regular cancer screening physical examination, residents can have a clearer understanding of their own health status, develop a healthy lifestyle and behavior habits, and help reduce the anxiety about the sudden disease [9][10][11][12] . However, early screening does not guarantee 100% accuracy and the improvement of survival rates, and many factors such as the age of patients, genetic inheritance, and lifestyle will also have an important impact on survival rates.…”

Section: Discussionmentioning

confidence: 99%

Comparison of screening results of urban cancer early diagnosis and early treatment project in 2023 and 2022 in Wuwei City

Sun,

Hu,

Cai

et al. 2024

Preprint

View full text Add to dashboard Cite

Objective To compare the screening results of urban cancer early diagnosis and early treatment project in Liangzhou District of Wuwei City in 2023 and 2022, analyze the characteristics of screening population changes, and provide optimization suggestions for the future development of urban cancer project. Methods The 2022–2023 screening data were extracted from the urban cancer screening system and matched with the telephone follow-up results of the cancer population, and the characteristics of the two-year screening population were compared by gender and age. Chi-square test was used for comparison between groups. Results From 2022 to 2023, a total of 6098 people participated in questionnaire assessment and 4400 people participated in clinical screening. In 2023, 1587 people were at high risk, with a high risk rate of 92.61%; In 2022, 3301 people are at high risk, with a high risk rate of 80.06%. The two-year data comparison found that both the overall risk rate comparison and the gender comparison, the risk rate in 2023 was higher than that in 2022. However, by age group comparison, it is found that in 2022, the middle age group has a higher risk rate, and in 2023, the high age group has a higher risk rate. In 2023, 1,975 people will participate in assessment and 1,560 people will participate in clinical screening. The participation rate of clinical screening was 78.99%. In 2023, 36.35% men and 63.65% women will participate in clinical screening. In 2022, 33.06% of men and 66.94% of women participated in clinical screening. The sex composition ratio of the population participating in clinical screening at two years was similar. The proportion of people participating in clinical screening in 2022 and 2023 was compared by age group, and it was found that the three age groups of 50–64 years old accounted for the largest number of people, and the 70–74 years old group accounted for the least. Compared with 2022, the detection rate of cancer in all parts of 2023 has decreased, and the detection rate of other positive lesions besides cancer in liver, breast, colorectal and upper digestive tract has also decreased, but the detection rate of other positive lesions besides cancer in lung has increased by 17.98%. Conclusion There is still room for improvement in the participation rate of clinical screening, and more measures should be taken to encourage high-risk groups to complete clinical screening programs. In addition, the ability to detect diseases in staff still needs to be improved.

show abstract

Robotic-assisted thoracoscopic segmentectomy: there is a long way to go

Cited by 2 publications

References 23 publications

Robotic Anatomical Segmentectomy: An Analysis of the Learning Curve

Robotic Anatomical Segmentectomy: An Analysis of the Learning Curve

Comparison of screening results of urban cancer early diagnosis and early treatment project in 2023 and 2022 in Wuwei City

Contact Info

Product

Resources

About